Loading clinical trials...
Loading clinical trials...
This study explores the use of novel, highly sensitive quantum-based magnetometers for creating a contactless human-machine interface for consumer applications. These sensors can detect extremely weak biomagnetic fields, such as those from the brain's neural activity (magnetoencephalography), at room temperature. The research aims to quantify interfering biological signals and evaluate the system's performance in detecting user intention for a simple use case. The results will serve as a foundation for developing future applications.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Robert Bosch Gmbh, Corporate Sector Research and Advance Engineering
Renningen, Baden-Wurttemberg, Germany
Start Date
June 21, 2024
Primary Completion Date
May 1, 2026
Completion Date
May 1, 2026
Last Updated
March 12, 2026
12
ESTIMATED participants
Magnetoencephalography using quantum-based magnetometers
DEVICE
Lead Sponsor
Robert Bosch GmbH
NCT07483606
NCT06342713
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions